Nabbout R, Arzimanoglou A, Chin RFM, Grinspan Z, Speechley K, Camfield P.
2019.
The evaluation and costs of transition programs for youth with epilepsy.. Epilepsy Behav. 93:133-137.
Nabbout R, Arzimanoglou A, Chin RFM, Grinspan Z, Speechley K, Camfield P.
2019.
The evaluation and costs of transition programs for youth with epilepsy.. Epilepsy Behav. 93:133-137.
Creber RMMasterso, Grossman LV, Ryan B, Qian M, Polubriaginof FCG, Restaino S, Bakken S, Hripcsak G, Vawdrey DK.
2019.
Engaging hospitalized patients with personalized health information: a randomized trial of an inpatient portal.. J Am Med Inform Assoc. 26(2):115-123.
Chagoya G, Kwatra SG, Nanni CW, Roberts CM, Phillips SM, Nullmeyergh S, Gilmore SP, Spasojevic I, Corcoran DL, Young CC et al..
2020.
Efficacy of osimertinib against EGFRvIII+ glioblastoma.. Oncotarget. 11(22):2074-2082.
Chagoya G, Kwatra SG, Nanni CW, Roberts CM, Phillips SM, Nullmeyergh S, Gilmore SP, Spasojevic I, Corcoran DL, Young CC et al..
2020.
Efficacy of osimertinib against EGFRvIII+ glioblastoma.. Oncotarget. 11(22):2074-2082.